UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000007345
Receipt number R000008650
Scientific Title A phase 2 study of mid-term compliance and effectiveness of dasatinib therapy in patients with chronic myeloid leukemia.
Date of disclosure of the study information 2012/03/01
Last modified on 2016/02/21 18:09:08

No. Disposal Last modified on Item of update
1 Insert 2012/02/21 17:25:26
2 Update 2014/03/21 16:47:43 Recruitment status
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2015/08/21 22:27:58 Email
4 Update 2016/02/21 18:09:08 Recruitment status
Publication of results
Results